Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dietary Supplements | 66 | 2024 | 212 | 14.400 |
Why?
|
Micronutrients | 35 | 2024 | 48 | 10.910 |
Why?
|
Child Development | 29 | 2023 | 71 | 7.310 |
Why?
|
Docosahexaenoic Acids | 20 | 2021 | 87 | 6.720 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 22 | 2021 | 28 | 6.300 |
Why?
|
Maternal Nutritional Physiological Phenomena | 19 | 2022 | 52 | 5.970 |
Why?
|
Iron | 24 | 2024 | 103 | 5.440 |
Why?
|
Pregnancy | 86 | 2024 | 1127 | 5.240 |
Why?
|
Nutritional Status | 23 | 2023 | 73 | 4.840 |
Why?
|
Birth Weight | 21 | 2023 | 63 | 4.280 |
Why?
|
Malnutrition | 15 | 2022 | 29 | 4.180 |
Why?
|
Body Height | 22 | 2021 | 58 | 3.990 |
Why?
|
Infant | 82 | 2024 | 960 | 3.840 |
Why?
|
Female | 165 | 2024 | 14433 | 3.600 |
Why?
|
Diet | 21 | 2024 | 222 | 3.490 |
Why?
|
Folic Acid | 15 | 2024 | 31 | 3.410 |
Why?
|
Vietnam | 25 | 2024 | 41 | 3.270 |
Why?
|
Child, Preschool | 58 | 2023 | 1087 | 3.250 |
Why?
|
Anemia, Iron-Deficiency | 16 | 2021 | 27 | 3.240 |
Why?
|
Infant Nutritional Physiological Phenomena | 17 | 2022 | 35 | 3.200 |
Why?
|
Humans | 193 | 2024 | 26799 | 3.080 |
Why?
|
Infant, Newborn | 55 | 2024 | 845 | 2.990 |
Why?
|
Growth Disorders | 14 | 2024 | 20 | 2.710 |
Why?
|
Adult | 90 | 2024 | 7370 | 2.680 |
Why?
|
Prenatal Care | 14 | 2023 | 40 | 2.610 |
Why?
|
Mothers | 14 | 2023 | 107 | 2.570 |
Why?
|
Developing Countries | 19 | 2019 | 45 | 2.550 |
Why?
|
Preconception Care | 6 | 2019 | 17 | 2.500 |
Why?
|
Mexico | 27 | 2021 | 87 | 2.370 |
Why?
|
Double-Blind Method | 32 | 2021 | 399 | 2.340 |
Why?
|
Anemia | 14 | 2021 | 41 | 2.240 |
Why?
|
Child | 46 | 2023 | 2147 | 2.240 |
Why?
|
Pregnancy Complications | 10 | 2017 | 103 | 2.130 |
Why?
|
Weight Gain | 8 | 2022 | 73 | 2.120 |
Why?
|
Body Mass Index | 19 | 2024 | 382 | 2.110 |
Why?
|
Young Adult | 44 | 2024 | 2578 | 2.110 |
Why?
|
Body Weight | 18 | 2021 | 245 | 2.100 |
Why?
|
Postpartum Period | 8 | 2024 | 63 | 2.050 |
Why?
|
Child Nutrition Disorders | 4 | 2022 | 5 | 2.040 |
Why?
|
Growth | 10 | 2012 | 24 | 1.970 |
Why?
|
Adiposity | 6 | 2021 | 87 | 1.930 |
Why?
|
Cognition | 6 | 2023 | 294 | 1.870 |
Why?
|
Prenatal Exposure Delayed Effects | 7 | 2023 | 96 | 1.820 |
Why?
|
Fetal Development | 5 | 2024 | 21 | 1.790 |
Why?
|
Breast Feeding | 15 | 2024 | 87 | 1.700 |
Why?
|
Iron, Dietary | 11 | 2017 | 16 | 1.690 |
Why?
|
Adolescent | 41 | 2024 | 2954 | 1.690 |
Why?
|
Pregnancy Outcome | 12 | 2019 | 128 | 1.670 |
Why?
|
Fatty Acids, Omega-3 | 6 | 2019 | 30 | 1.660 |
Why?
|
Infant, Small for Gestational Age | 7 | 2016 | 12 | 1.570 |
Why?
|
Rural Population | 16 | 2018 | 88 | 1.560 |
Why?
|
Feeding Behavior | 9 | 2022 | 94 | 1.530 |
Why?
|
Thinness | 6 | 2024 | 16 | 1.510 |
Why?
|
Metabolic Syndrome | 4 | 2023 | 77 | 1.490 |
Why?
|
Fatty Acid Desaturases | 3 | 2021 | 15 | 1.470 |
Why?
|
Vitamin A | 10 | 2012 | 25 | 1.470 |
Why?
|
India | 26 | 2024 | 136 | 1.420 |
Why?
|
Cardiovascular Diseases | 6 | 2023 | 346 | 1.410 |
Why?
|
Mental Health | 4 | 2021 | 96 | 1.400 |
Why?
|
Male | 77 | 2024 | 12845 | 1.400 |
Why?
|
Child Nutritional Physiological Phenomena | 7 | 2023 | 21 | 1.370 |
Why?
|
Pregnant Women | 2 | 2022 | 23 | 1.350 |
Why?
|
Pediatric Obesity | 5 | 2021 | 70 | 1.340 |
Why?
|
Randomized Controlled Trials as Topic | 16 | 2020 | 357 | 1.300 |
Why?
|
Gestational Age | 8 | 2017 | 138 | 1.260 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2021 | 542 | 1.240 |
Why?
|
Ultrasonography, Prenatal | 3 | 2017 | 34 | 1.210 |
Why?
|
Fetal Growth Retardation | 5 | 2016 | 30 | 1.190 |
Why?
|
Maternal Exposure | 2 | 2018 | 16 | 1.110 |
Why?
|
Prevalence | 21 | 2022 | 469 | 1.100 |
Why?
|
Anthropometry | 13 | 2021 | 93 | 1.090 |
Why?
|
Overweight | 8 | 2021 | 108 | 1.080 |
Why?
|
Vitamin A Deficiency | 7 | 2014 | 9 | 1.080 |
Why?
|
Patient Compliance | 5 | 2016 | 75 | 1.070 |
Why?
|
Body Composition | 12 | 2024 | 260 | 1.040 |
Why?
|
Milk, Human | 8 | 2023 | 82 | 1.020 |
Why?
|
Obesity | 8 | 2023 | 645 | 1.010 |
Why?
|
Infant, Low Birth Weight | 5 | 2022 | 23 | 1.000 |
Why?
|
Socioeconomic Factors | 18 | 2024 | 240 | 0.980 |
Why?
|
Energy Intake | 11 | 2023 | 67 | 0.960 |
Why?
|
Nutritional Physiological Phenomena | 3 | 2020 | 6 | 0.960 |
Why?
|
Premature Birth | 6 | 2023 | 48 | 0.960 |
Why?
|
Babuvirus | 2 | 2014 | 2 | 0.960 |
Why?
|
Medication Adherence | 2 | 2017 | 46 | 0.950 |
Why?
|
Follow-Up Studies | 17 | 2021 | 981 | 0.940 |
Why?
|
Zinc | 8 | 2014 | 52 | 0.940 |
Why?
|
Cohort Effect | 2 | 2020 | 3 | 0.880 |
Why?
|
Longitudinal Studies | 20 | 2023 | 400 | 0.880 |
Why?
|
Parity | 7 | 2022 | 48 | 0.860 |
Why?
|
Motor Skills | 4 | 2018 | 32 | 0.850 |
Why?
|
Guatemala | 25 | 2024 | 30 | 0.850 |
Why?
|
Health Education | 3 | 2020 | 68 | 0.840 |
Why?
|
Food Preferences | 1 | 2022 | 20 | 0.830 |
Why?
|
Behavior Therapy | 2 | 2020 | 29 | 0.830 |
Why?
|
Transients and Migrants | 1 | 2022 | 3 | 0.800 |
Why?
|
Dietary Fats, Unsaturated | 2 | 2012 | 6 | 0.790 |
Why?
|
Residence Characteristics | 2 | 2024 | 101 | 0.770 |
Why?
|
Vitamins | 7 | 2024 | 22 | 0.760 |
Why?
|
Elettaria | 3 | 2019 | 3 | 0.750 |
Why?
|
Risk Factors | 15 | 2023 | 2013 | 0.750 |
Why?
|
Prospective Studies | 14 | 2023 | 1217 | 0.750 |
Why?
|
Metabolome | 1 | 2021 | 64 | 0.740 |
Why?
|
Inflammation | 5 | 2020 | 598 | 0.740 |
Why?
|
Head | 5 | 2015 | 16 | 0.740 |
Why?
|
Adipokines | 1 | 2020 | 9 | 0.730 |
Why?
|
Educational Status | 10 | 2012 | 111 | 0.720 |
Why?
|
Human Development | 1 | 2020 | 4 | 0.710 |
Why?
|
Infant Nutrition Disorders | 1 | 2020 | 1 | 0.700 |
Why?
|
Diarrhea | 7 | 2023 | 54 | 0.690 |
Why?
|
Nutritional Sciences | 1 | 2019 | 9 | 0.690 |
Why?
|
Phenylketonurias | 4 | 2023 | 4 | 0.680 |
Why?
|
Blood Pressure | 4 | 2018 | 351 | 0.680 |
Why?
|
Hemoglobins | 10 | 2021 | 116 | 0.680 |
Why?
|
Food, Fortified | 8 | 2021 | 22 | 0.670 |
Why?
|
Air Pollution, Indoor | 3 | 2024 | 9 | 0.660 |
Why?
|
Arm | 2 | 2015 | 35 | 0.630 |
Why?
|
Maternal Health Services | 3 | 2012 | 7 | 0.620 |
Why?
|
DNA Methylation | 3 | 2014 | 148 | 0.610 |
Why?
|
Cohort Studies | 12 | 2022 | 858 | 0.600 |
Why?
|
Environmental Pollutants | 1 | 2018 | 32 | 0.600 |
Why?
|
Nutritional Requirements | 5 | 2013 | 8 | 0.590 |
Why?
|
Rural Health | 4 | 2013 | 14 | 0.580 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2018 | 278 | 0.580 |
Why?
|
Parenting | 2 | 2017 | 56 | 0.570 |
Why?
|
Menstruation | 1 | 2017 | 9 | 0.570 |
Why?
|
Immune System | 2 | 2013 | 29 | 0.560 |
Why?
|
Cross-Sectional Studies | 16 | 2023 | 913 | 0.560 |
Why?
|
Nutrition Policy | 7 | 2014 | 22 | 0.550 |
Why?
|
Physical Examination | 1 | 2017 | 47 | 0.550 |
Why?
|
Linear Models | 10 | 2022 | 202 | 0.540 |
Why?
|
Interferon-gamma | 2 | 2016 | 102 | 0.540 |
Why?
|
Nutrition Assessment | 4 | 2015 | 16 | 0.540 |
Why?
|
Social Class | 6 | 2016 | 78 | 0.530 |
Why?
|
Attention | 1 | 2016 | 90 | 0.520 |
Why?
|
Health Plan Implementation | 2 | 2012 | 9 | 0.510 |
Why?
|
Education | 3 | 2010 | 33 | 0.500 |
Why?
|
Genome, Viral | 2 | 2019 | 28 | 0.500 |
Why?
|
Maternal Welfare | 2 | 2014 | 4 | 0.500 |
Why?
|
Aphids | 1 | 2014 | 1 | 0.490 |
Why?
|
Child Welfare | 2 | 2014 | 39 | 0.490 |
Why?
|
Fatty Acids, Unsaturated | 2 | 2016 | 65 | 0.490 |
Why?
|
Interleukins | 1 | 2016 | 108 | 0.490 |
Why?
|
Insect Vectors | 1 | 2014 | 12 | 0.490 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2016 | 244 | 0.480 |
Why?
|
Surveys and Questionnaires | 11 | 2020 | 915 | 0.480 |
Why?
|
Eicosapentaenoic Acid | 2 | 2011 | 4 | 0.480 |
Why?
|
Lactation | 6 | 2023 | 55 | 0.470 |
Why?
|
United States | 13 | 2024 | 2033 | 0.470 |
Why?
|
alpha-Linolenic Acid | 2 | 2011 | 4 | 0.470 |
Why?
|
Reassortant Viruses | 1 | 2014 | 1 | 0.470 |
Why?
|
Folic Acid Deficiency | 1 | 2014 | 5 | 0.460 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2014 | 9 | 0.460 |
Why?
|
Ferritins | 7 | 2014 | 23 | 0.450 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2016 | 27 | 0.450 |
Why?
|
Plant Diseases | 5 | 2019 | 36 | 0.440 |
Why?
|
Reproducibility of Results | 8 | 2023 | 748 | 0.440 |
Why?
|
Biomarkers | 5 | 2020 | 729 | 0.440 |
Why?
|
Infant Food | 6 | 2018 | 11 | 0.440 |
Why?
|
Poverty | 7 | 2024 | 79 | 0.430 |
Why?
|
Multivariate Analysis | 9 | 2016 | 297 | 0.430 |
Why?
|
Petroleum | 2 | 2024 | 34 | 0.430 |
Why?
|
Genetic Variation | 1 | 2014 | 229 | 0.420 |
Why?
|
Calcium Compounds | 1 | 2012 | 3 | 0.420 |
Why?
|
Sodium Hydroxide | 1 | 2012 | 9 | 0.420 |
Why?
|
Anesthesia, Closed-Circuit | 1 | 2012 | 3 | 0.420 |
Why?
|
Evoked Potentials, Auditory | 1 | 2012 | 3 | 0.410 |
Why?
|
Evoked Potentials, Visual | 1 | 2012 | 5 | 0.410 |
Why?
|
Ecosystem | 1 | 2014 | 205 | 0.410 |
Why?
|
Ventilators, Mechanical | 1 | 2012 | 10 | 0.410 |
Why?
|
Oxides | 1 | 2012 | 14 | 0.410 |
Why?
|
Fertility | 2 | 2005 | 58 | 0.410 |
Why?
|
Weight Reduction Programs | 3 | 2017 | 9 | 0.410 |
Why?
|
Lipids | 4 | 2023 | 195 | 0.400 |
Why?
|
Nutrition Surveys | 7 | 2022 | 27 | 0.390 |
Why?
|
Common Cold | 1 | 2011 | 1 | 0.390 |
Why?
|
Evidence-Based Medicine | 2 | 2016 | 140 | 0.390 |
Why?
|
Mexican Americans | 2 | 2002 | 13 | 0.380 |
Why?
|
Cooking | 4 | 2024 | 9 | 0.380 |
Why?
|
Domestic Violence | 1 | 2011 | 6 | 0.380 |
Why?
|
Health Policy | 1 | 2011 | 59 | 0.370 |
Why?
|
Influenza Vaccines | 1 | 2011 | 48 | 0.370 |
Why?
|
Influenza, Human | 1 | 2011 | 84 | 0.350 |
Why?
|
Maternal Age | 5 | 2022 | 25 | 0.340 |
Why?
|
Neurodevelopmental Disorders | 2 | 2020 | 8 | 0.340 |
Why?
|
Family Characteristics | 3 | 2020 | 46 | 0.340 |
Why?
|
Oryza | 2 | 2024 | 37 | 0.330 |
Why?
|
Dietary Proteins | 5 | 2020 | 30 | 0.330 |
Why?
|
Intelligence | 3 | 2016 | 27 | 0.330 |
Why?
|
Health Promotion | 6 | 2024 | 169 | 0.330 |
Why?
|
Particulate Matter | 3 | 2024 | 11 | 0.320 |
Why?
|
Blood Glucose | 5 | 2016 | 300 | 0.310 |
Why?
|
Poverty Areas | 1 | 2008 | 8 | 0.300 |
Why?
|
Imaging, Three-Dimensional | 2 | 2018 | 128 | 0.300 |
Why?
|
Depression | 2 | 2010 | 209 | 0.300 |
Why?
|
Schools | 4 | 2021 | 69 | 0.290 |
Why?
|
Africa South of the Sahara | 3 | 2023 | 11 | 0.290 |
Why?
|
Trace Elements | 4 | 2016 | 8 | 0.280 |
Why?
|
Research Design | 3 | 2019 | 173 | 0.280 |
Why?
|
Cluster Analysis | 3 | 2023 | 113 | 0.280 |
Why?
|
Diet Surveys | 4 | 2013 | 9 | 0.280 |
Why?
|
Diarrhea, Infantile | 4 | 2016 | 6 | 0.280 |
Why?
|
Hospitals | 2 | 2024 | 72 | 0.280 |
Why?
|
Developmental Disabilities | 3 | 2012 | 14 | 0.270 |
Why?
|
Choline | 2 | 2023 | 19 | 0.270 |
Why?
|
Risk Reduction Behavior | 2 | 2017 | 40 | 0.260 |
Why?
|
Reproduction | 3 | 2020 | 63 | 0.250 |
Why?
|
Contraception Behavior | 1 | 2005 | 15 | 0.250 |
Why?
|
Iodine | 2 | 2021 | 10 | 0.250 |
Why?
|
Food | 2 | 2023 | 31 | 0.240 |
Why?
|
Phylogeny | 3 | 2019 | 461 | 0.230 |
Why?
|
Interviews as Topic | 4 | 2020 | 149 | 0.230 |
Why?
|
Niacin | 1 | 2024 | 2 | 0.230 |
Why?
|
Air Pollutants | 1 | 2024 | 14 | 0.230 |
Why?
|
Focus Groups | 2 | 2016 | 89 | 0.230 |
Why?
|
Arachidonic Acid | 2 | 2016 | 18 | 0.230 |
Why?
|
Child Behavior | 2 | 2016 | 26 | 0.220 |
Why?
|
Diabetes Mellitus | 2 | 2017 | 207 | 0.220 |
Why?
|
Infant Formula | 2 | 2021 | 18 | 0.220 |
Why?
|
Cognition Disorders | 3 | 2017 | 181 | 0.220 |
Why?
|
Global Health | 2 | 2019 | 43 | 0.220 |
Why?
|
Chorioamnionitis | 1 | 2023 | 3 | 0.220 |
Why?
|
Rotavirus | 1 | 2023 | 1 | 0.220 |
Why?
|
Rotavirus Vaccines | 1 | 2023 | 3 | 0.220 |
Why?
|
Time Factors | 5 | 2017 | 1564 | 0.220 |
Why?
|
Treatment Outcome | 4 | 2017 | 2263 | 0.220 |
Why?
|
Middle Aged | 11 | 2022 | 6808 | 0.220 |
Why?
|
Air Pollution | 1 | 2023 | 13 | 0.210 |
Why?
|
Memory, Short-Term | 1 | 2023 | 62 | 0.210 |
Why?
|
Electric Impedance | 2 | 2020 | 30 | 0.210 |
Why?
|
Meals | 1 | 2022 | 20 | 0.210 |
Why?
|
Nutrition Disorders | 1 | 2002 | 2 | 0.210 |
Why?
|
Case-Control Studies | 3 | 2023 | 699 | 0.200 |
Why?
|
Feeding Methods | 2 | 2020 | 2 | 0.200 |
Why?
|
Developed Countries | 1 | 2002 | 7 | 0.200 |
Why?
|
Cough | 2 | 2012 | 11 | 0.200 |
Why?
|
Shigella | 1 | 2021 | 2 | 0.200 |
Why?
|
Cryptosporidiosis | 1 | 2021 | 3 | 0.200 |
Why?
|
Cryptosporidium | 1 | 2021 | 3 | 0.200 |
Why?
|
Live Birth | 1 | 2022 | 39 | 0.200 |
Why?
|
Veterans Health | 3 | 2017 | 6 | 0.200 |
Why?
|
Appetite | 1 | 2021 | 19 | 0.200 |
Why?
|
Life Style | 3 | 2017 | 82 | 0.190 |
Why?
|
Pilot Projects | 3 | 2024 | 388 | 0.190 |
Why?
|
Pregnancy Trimester, Second | 2 | 2011 | 18 | 0.190 |
Why?
|
Psychomotor Performance | 2 | 2015 | 72 | 0.190 |
Why?
|
Pesticide Residues | 1 | 2020 | 1 | 0.190 |
Why?
|
Hydrocarbons, Chlorinated | 1 | 2020 | 5 | 0.190 |
Why?
|
Pesticides | 1 | 2020 | 9 | 0.190 |
Why?
|
Mycotoxins | 1 | 2020 | 7 | 0.190 |
Why?
|
Gravidity | 2 | 2010 | 6 | 0.180 |
Why?
|
Odds Ratio | 3 | 2011 | 231 | 0.180 |
Why?
|
Malaria | 1 | 2020 | 15 | 0.180 |
Why?
|
Population Health | 1 | 2020 | 4 | 0.180 |
Why?
|
Child Nutrition Sciences | 1 | 2020 | 3 | 0.180 |
Why?
|
World Health Organization | 3 | 2015 | 10 | 0.180 |
Why?
|
Logistic Models | 3 | 2020 | 397 | 0.180 |
Why?
|
Retrospective Studies | 6 | 2023 | 2437 | 0.180 |
Why?
|
Asia, Southeastern | 1 | 2020 | 11 | 0.180 |
Why?
|
Morbidity | 4 | 2011 | 57 | 0.180 |
Why?
|
Egypt | 1 | 2019 | 2 | 0.170 |
Why?
|
Hookworm Infections | 2 | 2014 | 2 | 0.170 |
Why?
|
Adolescent Nutritional Physiological Phenomena | 1 | 2019 | 3 | 0.170 |
Why?
|
Triglycerides | 2 | 2015 | 116 | 0.170 |
Why?
|
Adolescent Behavior | 1 | 2020 | 67 | 0.170 |
Why?
|
Counseling | 1 | 2019 | 51 | 0.170 |
Why?
|
Leadership | 1 | 2019 | 49 | 0.170 |
Why?
|
Potyviridae | 1 | 2019 | 1 | 0.170 |
Why?
|
Georgia | 3 | 2018 | 21 | 0.160 |
Why?
|
Biomass | 3 | 2024 | 80 | 0.160 |
Why?
|
Non-alcoholic Fatty Liver Disease | 1 | 2020 | 61 | 0.160 |
Why?
|
Food Supply | 2 | 2023 | 26 | 0.160 |
Why?
|
Adipose Tissue | 2 | 2019 | 179 | 0.160 |
Why?
|
Infant Health | 1 | 2018 | 2 | 0.160 |
Why?
|
Data Accuracy | 1 | 2019 | 9 | 0.160 |
Why?
|
Epidemiological Monitoring | 1 | 2019 | 6 | 0.160 |
Why?
|
Escherichia coli | 1 | 2021 | 328 | 0.160 |
Why?
|
Medical Records | 1 | 2019 | 49 | 0.160 |
Why?
|
Thiopental | 1 | 1998 | 1 | 0.160 |
Why?
|
Ceramides | 1 | 2018 | 22 | 0.160 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 57 | 0.160 |
Why?
|
Anesthesia, Obstetrical | 1 | 1998 | 2 | 0.160 |
Why?
|
Anesthesia, Epidural | 1 | 1998 | 7 | 0.160 |
Why?
|
Home Care Services | 1 | 2018 | 37 | 0.160 |
Why?
|
Anesthetics, Intravenous | 1 | 1998 | 14 | 0.160 |
Why?
|
Deficiency Diseases | 2 | 2020 | 6 | 0.160 |
Why?
|
Animals | 8 | 2024 | 9934 | 0.160 |
Why?
|
Xylenes | 1 | 2018 | 2 | 0.160 |
Why?
|
Maternal-Fetal Exchange | 1 | 2018 | 10 | 0.160 |
Why?
|
Toluene | 1 | 2018 | 11 | 0.150 |
Why?
|
Respiratory Function Tests | 1 | 2018 | 26 | 0.150 |
Why?
|
Efficiency, Organizational | 1 | 2018 | 13 | 0.150 |
Why?
|
Nitrogen Oxides | 1 | 2018 | 40 | 0.150 |
Why?
|
Benzene | 1 | 2018 | 11 | 0.150 |
Why?
|
Fatty Acids | 1 | 2019 | 198 | 0.150 |
Why?
|
Program Evaluation | 1 | 2018 | 159 | 0.150 |
Why?
|
Birth Certificates | 2 | 2019 | 3 | 0.150 |
Why?
|
Birth Rate | 2 | 2010 | 11 | 0.150 |
Why?
|
Public Health | 1 | 2018 | 84 | 0.150 |
Why?
|
Yogurt | 1 | 2017 | 1 | 0.150 |
Why?
|
Stillbirth | 1 | 2017 | 14 | 0.150 |
Why?
|
Databases, Factual | 2 | 2012 | 251 | 0.150 |
Why?
|
Infant Mortality | 1 | 2017 | 14 | 0.150 |
Why?
|
Psychosocial Deprivation | 1 | 2017 | 1 | 0.150 |
Why?
|
Vitamin B Complex | 1 | 2017 | 4 | 0.150 |
Why?
|
C-Reactive Protein | 3 | 2012 | 93 | 0.150 |
Why?
|
Regression Analysis | 2 | 2016 | 209 | 0.140 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 496 | 0.140 |
Why?
|
Lyssavirus | 1 | 2017 | 1 | 0.140 |
Why?
|
Rhabdoviridae Infections | 1 | 2017 | 2 | 0.140 |
Why?
|
Chiroptera | 1 | 2017 | 6 | 0.140 |
Why?
|
Infant, Premature | 3 | 2014 | 133 | 0.140 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 82 | 0.140 |
Why?
|
Patient Participation | 1 | 2017 | 52 | 0.140 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 437 | 0.140 |
Why?
|
Psychological Tests | 1 | 2016 | 21 | 0.140 |
Why?
|
Viral Proteins | 2 | 2019 | 62 | 0.140 |
Why?
|
Mastication | 1 | 2016 | 3 | 0.140 |
Why?
|
Evaluation Studies as Topic | 1 | 2016 | 43 | 0.130 |
Why?
|
Veterans | 1 | 2017 | 66 | 0.130 |
Why?
|
Genotyping Techniques | 1 | 2016 | 20 | 0.130 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 80 | 0.130 |
Why?
|
Random Allocation | 1 | 2016 | 148 | 0.130 |
Why?
|
Risk | 1 | 2016 | 133 | 0.130 |
Why?
|
Health Priorities | 2 | 2012 | 7 | 0.130 |
Why?
|
Organ Size | 1 | 2015 | 82 | 0.130 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 203 | 0.130 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 364 | 0.130 |
Why?
|
Growth Charts | 1 | 2015 | 3 | 0.130 |
Why?
|
Aging | 4 | 2010 | 952 | 0.130 |
Why?
|
Waist Circumference | 1 | 2015 | 18 | 0.130 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2015 | 4 | 0.120 |
Why?
|
Cholesterol, HDL | 1 | 2015 | 59 | 0.120 |
Why?
|
Cholesterol, LDL | 1 | 2015 | 65 | 0.120 |
Why?
|
Musa | 1 | 2014 | 1 | 0.120 |
Why?
|
Alleles | 1 | 2016 | 347 | 0.120 |
Why?
|
Bone Density | 1 | 2016 | 99 | 0.120 |
Why?
|
Antitubercular Agents | 1 | 2015 | 17 | 0.120 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2014 | 19 | 0.120 |
Why?
|
Retinol-Binding Proteins | 1 | 2014 | 6 | 0.120 |
Why?
|
Body Size | 2 | 2014 | 30 | 0.120 |
Why?
|
RNA, Long Noncoding | 1 | 2014 | 24 | 0.120 |
Why?
|
Fever | 2 | 2012 | 30 | 0.120 |
Why?
|
Incidence | 4 | 2017 | 545 | 0.120 |
Why?
|
Homologous Recombination | 1 | 2014 | 9 | 0.120 |
Why?
|
Biopterin | 1 | 2013 | 1 | 0.120 |
Why?
|
DNA, Viral | 1 | 2014 | 50 | 0.110 |
Why?
|
Sequence Alignment | 1 | 2014 | 110 | 0.110 |
Why?
|
Sex Characteristics | 4 | 2019 | 162 | 0.110 |
Why?
|
Seeds | 1 | 2013 | 10 | 0.110 |
Why?
|
Women, Working | 1 | 2013 | 4 | 0.110 |
Why?
|
Dairying | 1 | 2013 | 7 | 0.110 |
Why?
|
Leg | 1 | 2014 | 131 | 0.110 |
Why?
|
Evolution, Molecular | 1 | 2014 | 80 | 0.110 |
Why?
|
Insulin | 1 | 2015 | 309 | 0.110 |
Why?
|
HIV Infections | 1 | 1995 | 146 | 0.110 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2013 | 5 | 0.110 |
Why?
|
Haplotypes | 1 | 2014 | 279 | 0.110 |
Why?
|
Base Sequence | 1 | 2014 | 573 | 0.110 |
Why?
|
Nervous System | 1 | 2012 | 12 | 0.110 |
Why?
|
Age Factors | 4 | 2019 | 714 | 0.100 |
Why?
|
Equipment Safety | 1 | 2012 | 18 | 0.100 |
Why?
|
Adsorption | 1 | 2012 | 31 | 0.100 |
Why?
|
Iron Compounds | 1 | 2012 | 4 | 0.100 |
Why?
|
Regional Health Planning | 1 | 2012 | 3 | 0.100 |
Why?
|
Equipment Failure | 1 | 2012 | 31 | 0.100 |
Why?
|
Patient Safety | 1 | 2012 | 36 | 0.100 |
Why?
|
alpha Karyopherins | 1 | 2012 | 1 | 0.100 |
Why?
|
Begomovirus | 1 | 2012 | 1 | 0.100 |
Why?
|
Nuclear Localization Signals | 1 | 2012 | 9 | 0.100 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 1034 | 0.100 |
Why?
|
Copper | 1 | 2012 | 43 | 0.100 |
Why?
|
Equipment Design | 1 | 2012 | 211 | 0.100 |
Why?
|
Respiratory Sounds | 1 | 2011 | 5 | 0.100 |
Why?
|
Intention to Treat Analysis | 1 | 2011 | 13 | 0.100 |
Why?
|
Contraceptives, Oral | 2 | 2002 | 22 | 0.100 |
Why?
|
Ascorbic Acid | 2 | 2002 | 24 | 0.100 |
Why?
|
Plant Proteins | 1 | 2012 | 64 | 0.100 |
Why?
|
Linoleic Acid | 1 | 2011 | 1 | 0.100 |
Why?
|
Skinfold Thickness | 2 | 2014 | 19 | 0.090 |
Why?
|
Ghana | 2 | 2021 | 5 | 0.090 |
Why?
|
Depression, Postpartum | 1 | 2011 | 12 | 0.090 |
Why?
|
Body Constitution | 2 | 2003 | 11 | 0.090 |
Why?
|
Health Behavior | 2 | 2017 | 152 | 0.090 |
Why?
|
Social Behavior Disorders | 1 | 2010 | 2 | 0.090 |
Why?
|
Age Distribution | 3 | 2006 | 70 | 0.090 |
Why?
|
Kenya | 4 | 2013 | 31 | 0.090 |
Why?
|
Eating | 2 | 2024 | 66 | 0.090 |
Why?
|
Quality of Life | 1 | 2013 | 462 | 0.090 |
Why?
|
Urban Population | 1 | 2010 | 70 | 0.090 |
Why?
|
Mental Disorders | 1 | 2010 | 103 | 0.080 |
Why?
|
Puerperal Disorders | 1 | 2009 | 14 | 0.080 |
Why?
|
Fetal Blood | 1 | 2009 | 37 | 0.080 |
Why?
|
Infant Care | 1 | 2009 | 4 | 0.080 |
Why?
|
Minerals | 1 | 2009 | 15 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2016 | 206 | 0.080 |
Why?
|
Income | 2 | 2006 | 38 | 0.080 |
Why?
|
Cost-Benefit Analysis | 1 | 2008 | 108 | 0.080 |
Why?
|
Indians, North American | 1 | 2012 | 508 | 0.080 |
Why?
|
Educational Measurement | 1 | 2008 | 111 | 0.070 |
Why?
|
Intelligence Tests | 3 | 2012 | 25 | 0.070 |
Why?
|
Protoporphyrins | 2 | 2012 | 11 | 0.070 |
Why?
|
Lycopersicon esculentum | 1 | 2006 | 3 | 0.070 |
Why?
|
Capsid Proteins | 1 | 2006 | 12 | 0.070 |
Why?
|
Hygiene | 1 | 2006 | 34 | 0.070 |
Why?
|
United States Department of Veterans Affairs | 2 | 2016 | 26 | 0.070 |
Why?
|
Brain | 1 | 2011 | 696 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2006 | 194 | 0.060 |
Why?
|
Urban Health | 1 | 2005 | 12 | 0.060 |
Why?
|
Marital Status | 1 | 2005 | 16 | 0.060 |
Why?
|
Vitamin D | 2 | 2016 | 44 | 0.060 |
Why?
|
Diet Records | 2 | 2017 | 10 | 0.060 |
Why?
|
Abortion, Induced | 1 | 2005 | 16 | 0.060 |
Why?
|
Physical Fitness | 1 | 2005 | 61 | 0.060 |
Why?
|
Data Collection | 1 | 2005 | 101 | 0.060 |
Why?
|
Africa | 1 | 2004 | 13 | 0.060 |
Why?
|
Asia | 1 | 2004 | 19 | 0.060 |
Why?
|
Dietary Carbohydrates | 2 | 2015 | 22 | 0.060 |
Why?
|
Magnesium | 1 | 2024 | 40 | 0.060 |
Why?
|
Hospitals, Public | 1 | 2023 | 2 | 0.060 |
Why?
|
Cambodia | 1 | 2023 | 10 | 0.060 |
Why?
|
Dietary Fats | 2 | 2015 | 55 | 0.060 |
Why?
|
Embryonic and Fetal Development | 1 | 2003 | 9 | 0.060 |
Why?
|
Soot | 1 | 2023 | 1 | 0.060 |
Why?
|
Milk | 2 | 2013 | 21 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2005 | 162 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 587 | 0.050 |
Why?
|
Hot Temperature | 1 | 2024 | 84 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2024 | 80 | 0.050 |
Why?
|
Parturition | 1 | 2023 | 16 | 0.050 |
Why?
|
Walking | 1 | 2004 | 130 | 0.050 |
Why?
|
ROC Curve | 2 | 2014 | 137 | 0.050 |
Why?
|
Carbon Monoxide | 1 | 2023 | 47 | 0.050 |
Why?
|
Self Report | 2 | 2013 | 116 | 0.050 |
Why?
|
Vitamin B 12 | 1 | 2022 | 6 | 0.050 |
Why?
|
Models, Statistical | 3 | 2010 | 118 | 0.050 |
Why?
|
Antinematodal Agents | 1 | 2002 | 3 | 0.050 |
Why?
|
Ascariasis | 1 | 2002 | 2 | 0.050 |
Why?
|
Phenylalanine | 1 | 2022 | 23 | 0.050 |
Why?
|
National Health Programs | 1 | 2002 | 3 | 0.050 |
Why?
|
Trichuriasis | 1 | 2002 | 5 | 0.050 |
Why?
|
Alkaline Phosphatase | 2 | 2013 | 31 | 0.050 |
Why?
|
Health Planning Guidelines | 1 | 2002 | 6 | 0.050 |
Why?
|
Adaptation, Ocular | 1 | 2002 | 7 | 0.050 |
Why?
|
Body Weights and Measures | 2 | 2018 | 17 | 0.050 |
Why?
|
Darkness | 1 | 2002 | 17 | 0.050 |
Why?
|
Mebendazole | 1 | 2002 | 10 | 0.050 |
Why?
|
Methionine | 1 | 2022 | 37 | 0.050 |
Why?
|
Hydrocortisone | 1 | 2023 | 88 | 0.050 |
Why?
|
Avitaminosis | 1 | 2002 | 2 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2002 | 54 | 0.050 |
Why?
|
Promoter Regions, Genetic | 2 | 2014 | 332 | 0.050 |
Why?
|
Thailand | 2 | 2012 | 11 | 0.050 |
Why?
|
Sodium Chloride, Dietary | 1 | 2021 | 12 | 0.050 |
Why?
|
Cholesterol | 1 | 2002 | 181 | 0.050 |
Why?
|
Smoking | 1 | 2005 | 465 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2002 | 233 | 0.050 |
Why?
|
Immunoradiometric Assay | 1 | 2000 | 1 | 0.050 |
Why?
|
Transferrin | 1 | 2000 | 8 | 0.050 |
Why?
|
Colorimetry | 1 | 2000 | 14 | 0.050 |
Why?
|
Exercise | 1 | 2005 | 451 | 0.050 |
Why?
|
Fluorometry | 1 | 2000 | 7 | 0.050 |
Why?
|
Food Contamination | 1 | 2020 | 22 | 0.050 |
Why?
|
Malawi | 1 | 2020 | 2 | 0.050 |
Why?
|
Aspartate Aminotransferases | 1 | 2020 | 20 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2020 | 25 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2000 | 128 | 0.040 |
Why?
|
Absorptiometry, Photon | 1 | 2020 | 100 | 0.040 |
Why?
|
Menarche | 1 | 1999 | 7 | 0.040 |
Why?
|
Coitus | 1 | 1999 | 14 | 0.040 |
Why?
|
Labor, Obstetric | 1 | 1999 | 11 | 0.040 |
Why?
|
Polyproteins | 1 | 2019 | 1 | 0.040 |
Why?
|
Genome Size | 1 | 2019 | 7 | 0.040 |
Why?
|
Open Reading Frames | 1 | 2019 | 38 | 0.040 |
Why?
|
Vermont | 1 | 2019 | 1 | 0.040 |
Why?
|
Ideal Body Weight | 1 | 2018 | 2 | 0.040 |
Why?
|
New York City | 1 | 2019 | 16 | 0.040 |
Why?
|
Tobacco | 2 | 2012 | 86 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 472 | 0.040 |
Why?
|
Cephalometry | 1 | 2018 | 27 | 0.040 |
Why?
|
Checklist | 1 | 2018 | 21 | 0.040 |
Why?
|
Health Status | 1 | 1999 | 145 | 0.040 |
Why?
|
Comparative Effectiveness Research | 1 | 2018 | 12 | 0.040 |
Why?
|
Freezing | 1 | 1998 | 21 | 0.040 |
Why?
|
Sample Size | 1 | 2018 | 17 | 0.040 |
Why?
|
Quality Control | 1 | 2018 | 20 | 0.040 |
Why?
|
Maternal Health | 1 | 2018 | 2 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2018 | 72 | 0.040 |
Why?
|
Students | 1 | 2020 | 188 | 0.040 |
Why?
|
Executive Function | 1 | 2018 | 24 | 0.040 |
Why?
|
Work Capacity Evaluation | 1 | 1998 | 1 | 0.040 |
Why?
|
Powders | 1 | 2017 | 18 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2017 | 125 | 0.040 |
Why?
|
Software | 1 | 2018 | 121 | 0.040 |
Why?
|
Preventive Health Services | 1 | 2017 | 15 | 0.040 |
Why?
|
Rabies | 1 | 2017 | 1 | 0.040 |
Why?
|
Rabies virus | 1 | 2017 | 1 | 0.040 |
Why?
|
Portion Size | 1 | 2017 | 5 | 0.040 |
Why?
|
Social Environment | 1 | 2017 | 56 | 0.040 |
Why?
|
Qualitative Research | 1 | 2018 | 169 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2017 | 66 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 509 | 0.030 |
Why?
|
Demography | 1 | 2017 | 91 | 0.030 |
Why?
|
Mental Recall | 1 | 2017 | 45 | 0.030 |
Why?
|
Candy | 1 | 2016 | 2 | 0.030 |
Why?
|
Risk Assessment | 1 | 2019 | 586 | 0.030 |
Why?
|
Dairy Products | 1 | 2016 | 5 | 0.030 |
Why?
|
Phenylalanine Hydroxylase | 1 | 2016 | 1 | 0.030 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 1995 | 13 | 0.030 |
Why?
|
Emigration and Immigration | 2 | 2005 | 8 | 0.030 |
Why?
|
Sex Distribution | 2 | 2005 | 76 | 0.030 |
Why?
|
Respiratory Tract Infections | 1 | 1995 | 37 | 0.030 |
Why?
|
Calcium | 1 | 2016 | 231 | 0.030 |
Why?
|
Outpatients | 1 | 2015 | 42 | 0.030 |
Why?
|
Fetal Nutrition Disorders | 1 | 2014 | 1 | 0.030 |
Why?
|
Bolivia | 1 | 2014 | 3 | 0.030 |
Why?
|
Wasting Syndrome | 1 | 2014 | 7 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 213 | 0.030 |
Why?
|
Community Health Centers | 1 | 2014 | 13 | 0.030 |
Why?
|
Analysis of Variance | 1 | 1995 | 388 | 0.030 |
Why?
|
Th1-Th2 Balance | 1 | 2013 | 3 | 0.030 |
Why?
|
Interleukin-13 | 1 | 2013 | 6 | 0.030 |
Why?
|
Placebos | 1 | 2013 | 45 | 0.030 |
Why?
|
Georgia (Republic) | 1 | 2013 | 1 | 0.030 |
Why?
|
Serum Albumin | 1 | 2013 | 35 | 0.030 |
Why?
|
Survival Analysis | 1 | 2013 | 277 | 0.030 |
Why?
|
Bias | 1 | 2013 | 38 | 0.030 |
Why?
|
Health Surveys | 1 | 2013 | 77 | 0.030 |
Why?
|
Carbonated Beverages | 1 | 2012 | 3 | 0.030 |
Why?
|
Hemoglobin A | 1 | 2012 | 2 | 0.030 |
Why?
|
Adolescent Health Services | 1 | 2012 | 3 | 0.030 |
Why?
|
Child Health Services | 1 | 2012 | 7 | 0.030 |
Why?
|
Ethiopia | 1 | 2012 | 9 | 0.030 |
Why?
|
Nigeria | 1 | 2012 | 17 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2012 | 16 | 0.030 |
Why?
|
Acute-Phase Proteins | 1 | 2011 | 4 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2012 | 66 | 0.020 |
Why?
|
Area Under Curve | 1 | 2012 | 93 | 0.020 |
Why?
|
Cattle | 1 | 2013 | 383 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2013 | 143 | 0.020 |
Why?
|
Protein Transport | 1 | 2012 | 152 | 0.020 |
Why?
|
Task Performance and Analysis | 1 | 2011 | 37 | 0.020 |
Why?
|
Fluid Therapy | 1 | 2010 | 14 | 0.020 |
Why?
|
Protein Binding | 1 | 2012 | 631 | 0.020 |
Why?
|
Anxiety | 1 | 2010 | 133 | 0.020 |
Why?
|
Weaning | 1 | 2009 | 17 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2010 | 237 | 0.020 |
Why?
|
Beverages | 1 | 2008 | 24 | 0.020 |
Why?
|
Aged | 1 | 2017 | 5158 | 0.020 |
Why?
|
Urbanization | 1 | 2006 | 6 | 0.020 |
Why?
|
Life Expectancy | 1 | 2006 | 20 | 0.020 |
Why?
|
Agrobacterium tumefaciens | 1 | 2006 | 5 | 0.020 |
Why?
|
Plants, Genetically Modified | 1 | 2006 | 23 | 0.020 |
Why?
|
Drinking | 1 | 2006 | 8 | 0.020 |
Why?
|
RNA Stability | 1 | 2006 | 27 | 0.020 |
Why?
|
Maternal Behavior | 1 | 2006 | 7 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2006 | 25 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2006 | 100 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2006 | 110 | 0.020 |
Why?
|
Population Surveillance | 1 | 2006 | 85 | 0.020 |
Why?
|
Hand Disinfection | 1 | 2006 | 35 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2005 | 17 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2005 | 49 | 0.020 |
Why?
|
Birth Order | 1 | 2004 | 5 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2006 | 398 | 0.020 |
Why?
|
Intergenerational Relations | 1 | 2004 | 11 | 0.010 |
Why?
|
Motor Activity | 1 | 2004 | 144 | 0.010 |
Why?
|
Ascaris lumbricoides | 1 | 2002 | 2 | 0.010 |
Why?
|
Trichuris | 1 | 2002 | 5 | 0.010 |
Why?
|
Feces | 1 | 2002 | 107 | 0.010 |
Why?
|
Honduras | 1 | 2000 | 1 | 0.010 |
Why?
|